Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans

Migraine is three times as common in females as in males, and attacks may be more severe and difficult to treat in women. However, no study specifically addressed possible gender differences in response to antimigraine therapy. The objective of this study was to review the efficacy of frovatriptan v...

Descripción completa

Detalles Bibliográficos
Autores principales: Franconi, Flavia, Finocchi, Cinzia, Allais, Gianni, Omboni, Stefano, Tullo, Vincenzo, Campesi, Ilaria, Reggiardo, Giorgio, Benedetto, Chiara, Bussone, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2014
Materias:
SYMPOSIUM Migraine and its varieties
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035544/
https://www.ncbi.nlm.nih.gov/pubmed/24867845
http://dx.doi.org/10.1007/s10072-014-1750-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035544/
https://www.ncbi.nlm.nih.gov/pubmed/24867845
http://dx.doi.org/10.1007/s10072-014-1750-4

Ejemplares similares